panagene 产品代理

PANAMutyper ™ R

PNAClamp™

PANA RealTyper™

PNA

PANAGENE have been supplying Peptide Nucleic Acid (PNA) worldwide and exclusively since 2006 based on our unique invention of efficient synthesis of PNA with high purity, and nowadays we are possessing the best knowledge on PNA and the largest number of patents on the PNA and its applications in the world.

PNA, an artificial genetic material (a DNA mimic) invented at early 1990s, has been drawn much attention of researchers as a promising material candidate for especially diagnostic and therapeutic use, due to its advanced physicochemical properties such as strong binding affinity with complementary nucleic acids and superior biological/chemical stability.

Based on the advantage of PNA material and our accumulated knowledge, we have developed various innovative platform technologies on molecular diagnostics covering multiplexing, mutated gene specific amplification, SNP discrimination and so on. To meet rapidly changing diagnostic market needs, our efforts for innovation will continue.

PANAGENE has expertise especially in cancer-related molecular diagnostics including companion diagnostics using tissue or liquid biopsy specimens. Our advanced technology provides not only high level of detection but also simple and convenient procedure to be used easily in the front-line hospitals and clinical laboratories by themselves.

We have been developing and launching accurate and convenient in vitro diagnostic products consistently. We exercise strict quality management policy and make efforts to meet global standards and appropriate regulations for our IVD products. We believe that results of our efforts to produce IVD products will greatly contribute for helping human healthcare in the future.